| | | | | JAKARTA (Reuters) - Rising government and public hostility toward the lesbian, gay, bisexual and transgender (LGBT) community in Indonesia is threatening the battle against AIDS in the world's largest Muslim-majority country, activists and an official said. | | |
| | | LONDON (Reuters) - Britain marks the 70th anniversary of the founding of the National Health Service on Thursday, a moment of pride and concern for a country that has nurtured its growth into the largest publicly funded healthcare service in the world. | | |
| | | (Reuters Health) - Parents can make the most of their time at their child's routine pediatrician visits by preparing for each appointment, according to a new resource published in JAMA Pediatrics. | | |
| | | (Reuters Health) - Health clinics where low-income people in the U.S. obtain medical care don't always offer help with quitting smoking - and availability of that assistance may vary by patients' ethnicity and insurance, a recent study suggests. | | |
| | | (Reuters Health) - Waning eyesight may hasten the pace of cognitive decline in older people, suggests a U.S. study. | | |
| | | PARIS (Reuters) - Sanofi sees a more diversified pipeline driving a return to growth at its diabetes unit in the coming years and will consider acquisitions and partnerships to help boost performance, a company executive said on Tuesday. | | |
| | | ZURICH (Reuters) - Switzerland, which permits low potency cannabis but bans most marijuana for recreational use, aims to allow pilot studies on ways to relax its laws, its government said on Wednesday. | | |
| | | LONDON (Reuters) - Britain moved a step closer to legalizing the medicinal use of cannabis after a report concluded there are benefits for patients as the government reviews the rules to allow drugs derived from the banned plant. | | |
| | | (Reuters Health) - Folic acid fortification not only protects developing babies against certain birth defects but also supports healthy brain development through the teenage years, researchers report. | | |
| | | (Reuters Health) - Many breast cancer patients may miss out on genetic tests that could help pinpoint the ideal treatment regimen at least in part because their surgeons are uncomfortable discussing the pros and cons of these tests, a U.S. study suggests. | | |
|
| |
